|
TOR1AIP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
1.56950008545209E-10 |
| Normal-vs-Stage3 |
1.985490E-04 |
| Normal-vs-Stage4 |
3.316200E-02 |
| Stage1-vs-Stage2 |
4.029600E-01 |
| Stage1-vs-Stage3 |
1.093390E-01 |
| Stage1-vs-Stage4 |
3.953200E-01 |
| Stage2-vs-Stage3 |
3.562000E-01 |
| Stage2-vs-Stage4 |
7.001200E-01 |
| Stage3-vs-Stage4 |
8.768400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
6.92129997759139E-09 |
| Normal-vs-Asian |
8.3922999993824E-08 |
| Caucasian-vs-AfricanAmerican |
2.305200E-01 |
| Caucasian-vs-Asian |
6.449000E-01 |
| AfricanAmerican-vs-Asian |
4.430400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.56650000004976E-06 |
| Male-vs-Female |
3.637600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.36219999911236E-08 |
| Normal-vs-Extreme_Weight |
1.62436730732907E-12 |
| Normal-vs-Obese |
2.15990003660238E-09 |
| Normal-vs-Extreme_Obese |
4.755400E-04 |
| Normal_Weight-vs-Extreme_Weight |
2.613200E-01 |
| Normal_Weight-vs-Obese |
4.995200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.167800E-01 |
| Extreme_Weight-vs-Obese |
2.118400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.603600E-01 |
| Obese-vs-Extreme_Obese |
3.985800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.736200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.76869630053034E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.34240396576502E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.475200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.078430E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.474100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.884200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.461900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.076800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.26729959859517E-10 |
| Normal-VS-KIRP CIMP |
5.398800E-01 |
| Normal-VS-Unclassified PRCC |
1.62605999999288E-05 |
| Type1 PRCC-VS-Type2 PRCC |
8.897600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.384400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.794310E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.741600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.341200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.298020E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
8.836200E-02 |
| Normal-vs-N2 |
8.03860000000434E-05 |
| N0-vs-N1 |
1.027780E-02 |
| N0-vs-N2 |
4.564800E-01 |
| N1-vs-N2 |
4.382200E-01 |
|
|
